vanda pharmaceuticals inc
(VNDA:Consolidated Issue listed on NASDAQ Global Market)
Robert Repella R.Ph.,MBA
Former Chief Commercial Officer and Senior Vice President, Vanda Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 29 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Robert Repella, also known as Bob, R.Ph., MBA. has been Executive Vice President of Global Commercial Operations at CSL Ltd. since joining in July 1, 2014. Mr. Repella is responsible for a variety of global functions including sales, marketing, commercial development and medical affairs. Mr. Repella has over 30 years of commercial experience including biotech and specialty markets. He served as the Chief Commercial Officer and Senior Vice President of Vanda Pharmaceuticals, ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*
Rutgers, The State University of New Jersey
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Flemming Ornskov M.D., MBA, MPH||Managing Director, Chief Executive Officer and Director|
|Victor Grifols Roura||Chairman, Chief Executive Officer, President and Member of Appointments & Remuneration Committee|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥170.0M||Compensation as of Fiscal Year 2014.|